logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: cancer
Load new posts () and activity
Like Reblog Comment
text 2018-07-06 13:32
Peptide Cancer Vaccine Market Global Insights, 2018-2026

Peptide cancer vaccines aids to elicit and expand tumor-specific T-cells capable of controlling or eradicating tumor. This vaccine consists of one or more short or long amino acid sequences as tumor antigens, combined with vaccine adjuvant. In the recent past, results of clinical trials performed using peptide cancer vaccine had exhibited negative outcomes. So, researchers in the peptide vaccine have considered this as outdated therapy and declared it as no longer viable for cancer treatment. However, increasing progress in understanding critical role of immune adjuvants, modes of vaccine administration, and T cell dynamics has led to re-emergence of this approach for treating malignant disorders.

Click To Continue Reading on Peptide Cancer Vaccine Market

North America market accounted for the largest share in the global peptide cancer vaccine market, followed by Europe market in 2016. 

Furthermore, advantages involved in the preparation and usage of peptide vaccine are easy to synthesize, cost-effective, easy to prepare, and its application in clinical practice, flexibility in changing antigen, and lower risk of antigen-induced anaphylaxis are expected to foster growth of the peptide cancer vaccine market in the near future. Therefore, owing to these advantages, manufacturers are focusing on research, to develop peptide cancer vaccines. For instance, in April 2018, Boston Biomedical, Inc. involved in next generation cancer therapeutics, initiated dosing of the first patient in each of two clinical studies to evaluate the results of its affectability by using DSP-7888, an investigational cancer peptide vaccine. 

According to a National Cancer Institute, 2016, in the U.S., it was estimated that 16.8 million new cases of cancer were diagnosed with an approximate 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024. Furthermore, the World Health Organization (WHO) reported around 14 million cases of cancer and 8.2 million deaths caused by the disease in 2012. Among these, the common cases pertained to lung, colorectal, prostate, cervical, and breast cancer, which significantly has increased demand for peptide vaccines, in turn aiding in growth of the global peptide cancer vaccine market.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1634

Key Vendors:

 TapImmune, Merck, BrightPath Biotherapeutics, Sellas, BioLife Science, Boston Biomedical, VAXON Biotech, Lytix Biopharma, ISA Pharmaceuticals, Generex Biotechnology, OncoTherapy Science, Enzo Life Science, Antigen Express, Immatics Biotechnologies, Immatics, Immune Design, Immunomedics, Galena Biopharma, Generex Biotechnology Corporation, and Ultimovacs.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
 #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Visit our news Website: https://www.coherenttimes.org/

Like Reblog Comment
text 2018-06-27 08:23
Fallopian Tube Cancer Market Segments, Outlook, Growth and Competitive Landscape 2018

Fallopian Tube Cancer Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).

 

The report firstly introduced the Fallopian Tube Cancer basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

 

Download Free Sample Report @ https://www.radiantinsights.com/research/global-fallopian-tube-cancer-market-research-report-2018/request-sample

 

The report includes six parts, dealing with:
 
1.) Basic Information; 
2.) Asia Fallopian Tube Cancer Market; 
3.) North American Fallopian Tube Cancer Market; 
4.) European Fallopian Tube Cancer Market; 
5.) Market Entry and Investment Feasibility;
6.) Report Conclusion.

 

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/global-fallopian-tube-cancer-market-research-report-2018

 

Table of Contents

Part I Fallopian Tube Cancer Industry Overview

Chapter One Fallopian Tube Cancer Industry Overview
1.1 Fallopian Tube Cancer Definition
1.2 Fallopian Tube Cancer Classification Analysis
1.2.1 Fallopian Tube Cancer Main Classification Analysis
1.2.2 Fallopian Tube Cancer Main Classification Share Analysis
1.3 Fallopian Tube Cancer Application Analysis
1.3.1 Fallopian Tube Cancer Main Application Analysis
1.3.2 Fallopian Tube Cancer Main Application Share Analysis
1.4 Fallopian Tube Cancer Industry Chain Structure Analysis
1.5 Fallopian Tube Cancer Industry Development Overview
1.5.1 Fallopian Tube Cancer Product History Development Overview
1.5.1 Fallopian Tube Cancer Product Market Development Overview
1.6 Fallopian Tube Cancer Global Market Comparison Analysis
1.6.1 Fallopian Tube Cancer Global Import Market Analysis
1.6.2 Fallopian Tube Cancer Global Export Market Analysis
1.6.3 Fallopian Tube Cancer Global Main Region Market Analysis
1.6.4 Fallopian Tube Cancer Global Market Comparison Analysis
1.6.5 Fallopian Tube Cancer Global Market Development Trend Analysis

 

Explore all Report of this category @ https://www.radiantinsights.com/catalog/pharmaceutical

 

About Radiant Insights 
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

 

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: sales@radiantinsights.com
website: http://www.radiantinsights.com/

Like Reblog Comment
text 2018-05-30 13:22
Colorectal Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Colorectal Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global Colorectal Cancer Diagnostics Market: By Test (FOB, CTC Tests, CEA Tests, KRAS Mutation Tests, Immunohistochemistry, Others), By End User ( Hospitals, Diagnostic Centers and Cancer Research Institutes)  and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Colorectal Cancer Diagnostics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Colorectal Cancer Diagnostics Market

Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. Cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain

 

Market Dynamics: Colorectal Cancer Diagnostics Market

Global colorectal cancer diagnostics market is primarily driven by increase in prevalence of rectal and colon cancers globally. In addition, advent of novel screening tests for the cancer diagnosis such as DNA screening tests and other new techniques expected to bolster the market share over the forecast period. Furthermore, increase in geriatric population who are more prone to colorectal cancer and strengthening of government support for the screening of various types of cancers projected to boost the global colorectal cancer diagnostics market over the forecast period. However, lack of awareness and high cost of development coupled with stringent regulatory procedures for diagnostics expected to hamper the market share during the forecast period.

 

A sample of this report is available upon request @

 

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Colorectal Cancer Diagnostics Market

Colorectal cancer diagnostics market is segmented based on the type of condition, type of test, end user and geographical regions

Based on test, global colorectal cancer diagnostics market is segmented into the following:

  • FOB
  • CEA Tests
  • CTC Tests
  • Immunohistochemistry
  • KRAS Mutation Tests
  • Others

Based on end user, global colorectal cancer diagnostics market is segmented into the following:

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Institutes

Based on the geographical regions, global colorectal cancer diagnostics market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

Market Summary: Colorectal Cancer Diagnostics Market

Global colorectal cancer diagnostics market is expected to grow at significant rates owing to growing prevalence of cancer. According to National Cancer Institute Colorectal cancer is third most occurring form of cancer worldwide. And in 2012 more than one million people are diagnosed with the colorectal cancer. Faecal Occult Blood (FOB) tests are projected to have the major share in diagnostics segment owing to the accuracy. Market players in colorectal cancer diagnostics are focusing on the development of the new techniques and expanding their product portfolio. Furthermore, various programs are imitated by the government and non-government organizations to screen the colorectal cancer in around the globe likely to positively impact the market growth furthermore.

 

Regional Analysis:  Colorectal Cancer Diagnostics Market

Geographically, global colorectal cancer diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America colorectal cancer diagnostics market projected to have the significant growth rate owing to the increase in the rates of colorectal cancer and technological advancements in the diagnosis of the cancer. Europe colorectal cancer diagnostics market is expected to show propelled growth in global market owing the rise in R&D funding and healthcare expenditure in the region. Asia Pacific and Middle East and Africa markets projected to sluggish growth rates owing to the comparatively low colorectal cancer prevalence in the region. However, expansion of the international companies into the emerging Asian countries such as China and India expected to show lucrative growth opportunity in Asia Pacific region.

 

Competition Assessment: Colorectal Cancer Diagnostics Market

Some of the players in the global colorectal cancer diagnostics market include:

  • Sysmex Corporation (Japan)
  • Illumina, Inc. (U.S.)
  • Rosetta Genomics Ltd. (U.S.)
  • Danaher Corporation (U.S.)
  • Exact Science Corporation (U.S.)
  • Epigenomics AG (Germany)
  • Biocept, Inc. (U.S.)
  • Pathway Genomics Corporation (U.S.)
  • Foundation Medicine, Inc. (U.S.)
  • Cancer Genetics, Inc. (U.S.)

 

Notable Market Developments: Colorectal Cancer Diagnostics Market

  • In May 2015, EKF Diagnostics Holdings plc. has launched its next-generation sequencing technologyPrecision Path in partnership with Greenville Health Systems to test the colon cancer.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/colorectal-cancer-diagnostics-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

Like Reblog Comment
text 2018-05-30 10:28
Bladder Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Bladder Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global Bladder Cancer Diagnostics Market: Type of Condition (Transitional cell bladder cancer, Invasive bladder cancer, Superficial bladder cancer, Squamous cell bladder cancer, Other rare types), Type of Test (Cystoscopy, Biopsy, Urinalysis, Urine Cytology, Bladder Ultrasound), End user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Bladder Cancer Diagnostics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Bladder Cancer Diagnostics Market

Bladder cancer is a disease in which malignant cells are formed in the tissues of the bladder. Symptoms of bladder cancer include blood in the urine, pain with urination and low back pain. There are three types of bladder cancer that begin in the cells in the lining of the bladder. They are named as Transitional Cell Carcinoma, Squamous Cell Carcinoma, and Adenocarcinoma..

 

Market Dynamics: Bladder Cancer Diagnostics Market

Increasing incidence rate of bladder cancer cases, technological advancements and innovations with regard to the diagnosis of bladder cancer, government initiatives, the rise in aging of the population, and advanced health care services are expected to drive the market for bladder cancer diagnostics globally. In addition, the rise in awareness about bladder diseases, their available options for diagnosis in the market, and increasing health care expenditure are driving the global market for bladder cancer diagnostics. However, the rise in a number of patent expirations, asymptomatic nature of the disease, high cost associated tests, lack of awareness of the technologies factors restraining the revenue growth of the global bladder cancer diagnostics market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/bladder-cancer-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Scope: Bladder Cancer Diagnostics Market

Bladder Cancer Diagnostics market is segmented based on the type of condition, type of test, end user and geographical regions

Based on the type of condition, the market is segmented into the following:

  • Transitional cell bladder cancer
  • Invasive bladder cancer
  • Superficial bladder cancer
  • Squamous cell bladder cancer
  • Other rare types

Based on the type of test, the market is segmented into the following:

  • Biopsy
  • Urine Cytology
  • Cystoscopy
  • Bladder Ultrasound
  • Urinalysis

Based on the end user, the market is segmented into the following:

  • Diagnostic Centers
  • Hospitals
  • Ambulatory Surgical Centers

Based on the geographical regions, the market is segmented into the following:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/bladder-cancer-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

Market Summary: Bladder Cancer Diagnostics Market

According to the National Institute of Health, approximately 45,000 men and 17,000 women per year are diagnosed with bladder cancer only in U.S. Globally the market for bladder cancer is increasing rapidly and is expected to grow rapidly from 2016 to 2022. According to The American Cancer Society’s estimates for bladder cancer in the United States for 2017 are about 79,030 new cases of bladder cancer (about 60,490 in men and 18,540 in women) were diagnosed and about 16,870 deaths from bladder cancer (about 12,240 in men and 4,630 in women) are reporting .Bladder cancer accounts for about 5% of all new cancers in the US. It is the fourth most common cancer in men, but it is less common in women. In addition, the rise in awareness about bladder cancer and its available treatment options in the market, innovation in drug development, and subsequent technological advancements are expected to drive the market for bladder cancer diagnostics. Increasing number of mergers and acquisitions, the rise in a number of collaborations and partnerships, new product launches and growing awareness about the availability of bladder cancer diagnostics are some of the latest trends that have been observed in the market.

 

Regional Analysis:  Bladder Cancer Diagnostics Market

Geographically, global Bladder Cancer Diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America followed by Europe, comprises the largest market for bladder cancer diagnostics market due to the availability of advanced health care solutions, rise in bladder cancer cases, growing concern about bladder problems and developed health care infrastructure in the region. Asia is expected to experience a high growth rate in the bladder cancer diagnostics market in the next few years due to rise in bladder cancer cases, growing need for improved bladder cancer treatments and therapies, increasing awareness about cancer diagnosis, rise in health care expenditure and developing health care infrastructure in the region. Growing demographics and economies in the developing countries, such as India and China, are expected to lead to the rise of the bladder cancer diagnostics market in Asia Pacific region.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/bladder-cancer-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

Notable Market Developments:  Bladder Cancer Diagnostics Market

  • In May 2017. Roche Ltd. received USFDA approval for its VENTENA PD-L1 biomarket test pertaining to bladder cancer diagnosis.
  • In 2016, Pacific Edge Limited launched officially its third bladder cancer diagnostic test Cxbladder Monitor in U.S.

 

Competition Assessment: Bladder Cancer Diagnostics Market

Some of the players in the global Bladder Cancer Diagnostics market include:

  • Abbott Laboratories (U.S)
  • Pfizer (U.S)
  • Ariad Pharmaceuticals, Inc. (U.S)
  • Sanofi S.A (France)
  • Merck & Co., Inc. (U.S)
  • Novartis (Switzerland)
  • Becton, Dickinson & Co. (U.S)
  • Siemens Healthcare Inc. (Germany)
  • Eli Lilly and Co (U.S)
  • Hoffman-La Roche Ltd. (Switzerland)
  • AstraZeneca plc (UK)
  • GlaxoSmithKline Plc., etc. (UK)
  • Bristol-Myers Squibb (U.S)

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/bladder-cancer-diagnostics-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

Like Reblog Comment
review 2018-05-28 19:59
Bono, Helen Brown

I enjoyed this reflective story of a rescued cat. But it is so much more. I received this ARC copy for free and voluntarily chose to review it. I think the cat and Helen in the story did some healing for each other. I've given it a 4.5* rating and miss my own kitties more. Helen is a breast cancer surviver, who needed some me time as well. Watching Bono in his daily activities, gave her reflective time and examples of living for today. I was touched in many ways as this story evolved. This is basically a clean read.

More posts
Your Dashboard view:
Need help?